Re‐targeting of human lymphocytes expressing the T‐cell receptor gamma/delta to ovarian carcinoma cells by the use of bispecific monoclonal antibodies

单克隆抗体 分子生物学 T细胞受体 生物 T细胞 卵巢癌 抗体 多克隆抗体 细胞溶解 γδT细胞 癌症研究 免疫学 卵巢癌 细胞毒性T细胞 免疫系统 癌症 生物化学 体外 遗传学
作者
Silvano Ferrini,Ignazia Prigione,Serafina Mammouti,Maria I. Colnaghi,Sylvie Ménard,Alessandro Moretta,Lorenzo Moretta
出处
期刊:International Journal of Cancer [Wiley]
卷期号:44 (2): 245-250 被引量:24
标识
DOI:10.1002/ijc.2910440210
摘要

Abstract TcR gamma/delta + lymphocytes represent a small subset homogeneously composed of cytolytic T cells displaying unique motility and homing properties. Since the lytic machinery of these cells can be efficiently triggered by monoclonal antibodies (MAbs) directed to the TcR gamma/delta, such MAbs were used for the construction of bispecific MAbs in conjunction with an MAb specific for ovarian carcinoma cells. Hybrid hybridomas were obtained by fusing the Mov19 MAb (IgG 2a )‐producing hybridoma with either GI (IgG 2a ) or A13 (IgG 1 ) hybridomas, secreting MAbs specific for 2 peripheral blood subsets of TcR gamma/delta + lymphocytes. Hybrid hybridomas producing bispecific MAbs were screened according to their ability to induce ovarian carcinoma (IGROVI) target cell lysis by GI + or A13 + T cell clones, respectively. The Gl‐derived GM33.9 bispecific MAb induced selective lysis of Mov19 + ovarian carcinoma target cells only by GI + clones, whereas the A13‐derived AM 18.4 MAb was effective only in combination with A13 + clones. Neither the anti‐TcR gamma/ delta nor the Mov19 parental MAbs (used alone or in combination) induced target‐cell lysis. The hybrid nature (IgG 1 / lgG 2a ) of the AM 18.4 bispecific MAb was indicated by 2‐color immunofluorescence experiments. Thus, both ovarian carcinoma and A13 + effector cells were double stained by AM18.4 bispecific MAb followed by PE‐conjugated anti‐IgG 1 and FITC‐conjugated anti‐IgG 2a second reagents. Polyclonal TcR gamma/delta + cells were obtained by direct stimulation of peripheral blood mononuclear cells with Sepharose bead‐conjugated anti‐TcR gamma/delta MAbs and IL‐2. The lines so obtained contained more than 90% of TcR gamma/delta + cells after 4 weeks of culture, with an increase in TcR gamma/ delta + cell numbers ranging from 200 to 1,000‐fold. These TcR gamma/delta + cell lines efficiently lysed ovarian carcinoma target cells in the presence of bispecific MAb and may therefore represent a suitable source of effector cells for induction of ovarian carcinoma cell lysis.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
chilinwen完成签到 ,获得积分20
1秒前
大模型的应助被李大柱采纳,获得30
1秒前
cham发布了新的文献求助10
3秒前
sunny111发布了新的文献求助10
4秒前
开朗天问完成签到,获得积分10
4秒前
xiahaijun发布了新的文献求助10
4秒前
panpanliumin发布了新的文献求助40
4秒前
快乐曼荷完成签到 ,获得积分10
5秒前
朱雀发布了新的文献求助50
6秒前
6秒前
CodeCraft的应助被干亿先采纳,获得10
6秒前
WLJlele发布了新的文献求助10
7秒前
7秒前
8秒前
shine发布了新的文献求助10
10秒前
背后的凝莲完成签到 ,获得积分10
12秒前
xxf完成签到 ,获得积分10
12秒前
12秒前
13秒前
科研通AI6.2的应助被原神大王采纳,获得20
13秒前
bby发布了新的文献求助10
14秒前
牧青发布了新的文献求助20
14秒前
dream发布了新的文献求助10
15秒前
persist完成签到 ,获得积分10
15秒前
欢呼的访梦完成签到,获得积分10
16秒前
17秒前
无花果的应助被Lucky采纳,获得30
19秒前
反反复复完成签到,获得积分20
19秒前
今后的应助被lvsehx采纳,获得10
20秒前
20秒前
2871完成签到,获得积分10
20秒前
岳菊发布了新的文献求助10
20秒前
初景发布了新的文献求助10
20秒前
一一完成签到 ,获得积分10
21秒前
酷波er的应助被壮观雁易采纳,获得10
21秒前
dhfify完成签到,获得积分10
21秒前
黄志伟完成签到,获得积分20
22秒前
整齐唯雪完成签到,获得积分10
23秒前
自然的哈密瓜完成签到,获得积分10
23秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8189584
求助须知:如何正确求助?哪些是违规求助? 9576880
关于积分的说明 21849988
捐赠科研通 7787473
什么是DOI,文献DOI怎么找? 3435679
关于科研通互助平台的介绍 2559801
邀请新用户注册赠送积分活动 2482606